That led scientists to consider whether 15-PGDH might be involved in osteoarthritis, where stress on joints leads to the ...

Synartro is advancing the candidate drug SYN321, a novel intra-articular treatment for knee osteoarthritis, through a phase 1/2a clinical study focused on safety, tolerability, PK, and early efficacy ...

Infrapatellar fat pad (IPFP) glucocorticoid injections do not significantly reduce pain or effusion volume compared to ...

Does it seem like the number of people you know who have sustained knee injuries has increased recently? That's likely ...

Treatment for moderate to severe knee osteoarthritis includes non-surgical treatments and knee replacement surgery. The usual non-surgical treatment options are education, exercises, physiotherapy, ...

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering first-in-class therapeutics based on small-molecule inhibition of CLK/DYRK kinases, announced today that ...

This is a new way of regenerating adult tissue, and it has significant clinical promise for treating arthritis due to aging ...

Osteoarthritis affects millions of people worldwide. The joint condition often develops with age or after injuries and ...

The treatment also prevented the development of arthritis after knee injuries such as ACL tears often experienced by athletes ...

A single shot that appears to regrow worn knee cartilage and head off arthritis sounds like science fiction, yet early data ...

A treatment that blocks an age-related protein restored cartilage in aging and injured joints by reprogramming existing cells ...

IRVINE, Calif., Dec. 30, 2025 /PRNewswire/ -- Overture Orthopaedics, a privately held U.S.-based medical device company providing surgeons with innovative joint preservation solutions in sports ...